{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:48:44Z","timestamp":1790300924447,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,29]],"date-time":"2021-08-29T00:00:00Z","timestamp":1630195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,29]],"date-time":"2021-08-29T00:00:00Z","timestamp":1630195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10067-021-05772-x","type":"journal-article","created":{"date-parts":[[2021,8,29]],"date-time":"2021-08-29T10:04:31Z","timestamp":1630231471000},"page":"115-122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Significance of high serum IgG4 in complete or non-full-fledged IgG4-related disease\u2014a retrospective investigation of 845 patients and its clinical relevance"],"prefix":"10.1007","volume":"41","author":[{"given":"Hung-Cheng","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Yun","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Fang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Syuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Chih","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien-Tzung","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4154-4018","authenticated-orcid":false,"given":"Chang-Youh","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,29]]},"reference":[{"key":"5772_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/s10165-011-0508-6","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y et al (2012) A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 22:1\u201314","journal-title":"Mod Rheumatol"},{"key":"5772_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMra1104650","volume":"366","author":"J Stone","year":"2012","unstructured":"Stone J, Zen Y, Deshpande V (2012) IgG4-related disease. N Engl J Med 366:539\u2013551","journal-title":"N Engl J Med"},{"key":"5772_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13075-017-1432-8","volume":"19","author":"M Ozawa","year":"2017","unstructured":"Ozawa M, Fujinaga Y, Asano J et al (2017) Clinical features of IgG4-related periaortitis\/periarteritis based on the analysis of 179 patients with IgG4-related disease: a case-control study. Arthritis Res Ther 19:223","journal-title":"Arthritis Res Ther"},{"key":"5772_CR4","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3348\/kjr.2015.16.5.1056","volume":"16","author":"N Seo","year":"2015","unstructured":"Seo N, Kim JH, Byun JH, Lee SS, Kim HJ, Lee MG (2015) Immunoglobulin G4-related kidney disease: a comprehensive pictorial review of the imaging spectrum, mimickers, and clinicopathological characteristics. Korean J Radiol 16:1056\u20131067","journal-title":"Korean J Radiol"},{"key":"5772_CR5","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1056\/NEJMicm1809588","volume":"380","author":"J de la Fuente","year":"2019","unstructured":"de la Fuente J, Bird J (2019) Coronary arteritis in IgG4-related disease. N Engl J Med 380:2156. https:\/\/doi.org\/10.1056\/NEJMicm1809588","journal-title":"N Engl J Med"},{"key":"5772_CR6","first-page":"1097","volume":"10","author":"HC Tsai","year":"2019","unstructured":"Tsai HC, Liao HT, Tsai CY (2019) Retroperitoneal fibrosis with a damaged kidney in IgG4-related disease. J Clin Rheumatol 10:1097","journal-title":"J Clin Rheumatol"},{"key":"5772_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/14397595.2017.1290911","volume":"27","author":"H Umehara","year":"2017","unstructured":"Umehara H, Okazakib K, Nakamura T et al (2017) Current approach to the diagnosis of IgG4-related disease - combination of comprehensive diagnostic and organ-specific criteria. Mod Rheumatol 27:381\u2013391","journal-title":"Mod Rheumatol"},{"key":"5772_CR8","first-page":"1","volume":"8","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zeng Q, Zhu L, Gao J, Wang Z, Wang Z et al (2020) Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort. Rheumatology 8:1\u20139","journal-title":"Rheumatology"},{"issue":"9976","key":"5772_CR9","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720","volume":"385","author":"T Kamisawa","year":"2015","unstructured":"Kamisawa T, Zen Y, Pillai S, Stone JH (2015) IgG4-related disease. Lancet 385(9976):1460\u20131471. https:\/\/doi.org\/10.1016\/S0140-6736(14)60720","journal-title":"Lancet"},{"key":"5772_CR10","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.3390\/ijms21145082","volume":"21","author":"SC Hsieh","year":"2020","unstructured":"Hsieh SC, Shen CY, Liao HT et al (2020) The cellular and molecular bases of allergy, inflammation and tissue fibrosis in patients with IgG4-related disease. Int J Mol Sci 21:5082. https:\/\/doi.org\/10.3390\/ijms21145082","journal-title":"Int J Mol Sci"},{"key":"5772_CR11","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/S2665-9913(19)30017-7","volume":"1","author":"W Zhang","year":"2019","unstructured":"Zhang W, Stone JH (2019) Management of IgG4-related disease. Lancet Rheumatol 1:e55\u2013e65","journal-title":"Lancet Rheumatol"},{"key":"5772_CR12","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JK et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181\u20131192","journal-title":"Mod Pathol"},{"key":"5772_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1136\/annrheumdis-2019-216368","volume":"79","author":"RS Simpson","year":"2020","unstructured":"Simpson RS, Lau SKC, Lee JK (2020) Dupilumab as a novel steroid-sparing treatment for IgG4-related disease. Ann Rheum Dis 79:549\u2013550","journal-title":"Ann Rheum Dis"},{"key":"5772_CR14","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/art.27435","volume":"62","author":"A Khosroshahi","year":"2010","unstructured":"Khosroshahi A, Bloch DB, Deshpande V et al (2010) Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 62:1755\u20131762","journal-title":"Arthritis Rheum"},{"key":"5772_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y et al (2012) Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 22:21\u201330","journal-title":"Mod Rheumatol"},{"key":"5772_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/art.41120","volume":"72","author":"ZS Wallace","year":"2020","unstructured":"Wallace ZS, Naden RP, Chari S et al (2020) The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease. Arthritis Rheumatol 72:7\u201319","journal-title":"Arthritis Rheumatol"},{"key":"5772_CR17","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1136\/annrheumdis-2018-214603","volume":"78","author":"ZS Wallace","year":"2019","unstructured":"Wallace ZS, Zhang Y, Perugino CA et al (2019) Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis 78:406\u2013412. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214603","journal-title":"Ann Rheum Dis"},{"key":"5772_CR18","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","volume":"38","author":"T Kamisawa","year":"2003","unstructured":"Kamisawa T, Funata N, Hayashi Y et al (2003) A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 38:982\u2013984. https:\/\/doi.org\/10.1007\/s00535-003-1175-y","journal-title":"J Gastroenterol"},{"key":"5772_CR19","doi-asserted-by":"publisher","first-page":"e1275","DOI":"10.1097\/MD.0000000000001275","volume":"94","author":"A Fernandez-Codina","year":"2015","unstructured":"Fernandez-Codina A, Martinez-Valle F, Pinilla B et al (2015) IgG4-related disease: results from a multicenter Spanish registry. Medicine (Baltimore) 94:e1275","journal-title":"Medicine (Baltimore)"},{"key":"5772_CR20","doi-asserted-by":"publisher","first-page":"e680","DOI":"10.1097\/MD.0000000000000680","volume":"94","author":"D Inoue","year":"2015","unstructured":"Inoue D, Yoshida K, Yoneda N et al (2015) IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore) 94:e680","journal-title":"Medicine (Baltimore)"},{"key":"5772_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/BOR.0000000000000558","volume":"31","author":"R Kamekura","year":"2019","unstructured":"Kamekura R, Takahashi H, Ichimiya S (2019) New insights into IgG4-related disease: emerging new CD4+ T-cell subsets. Curr Opin Rheumatol 31:9\u201315","journal-title":"Curr Opin Rheumatol"},{"key":"5772_CR22","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","volume":"138","author":"H Mattoo","year":"2016","unstructured":"Mattoo H, Mahajan VS, Maehara T et al (2016) Clonal expansion of CD4 (+) cytotoxic T lymphocytes in patients with IgG4-related disease. J Allergy Clin Immunol Pract 138:825\u2013838","journal-title":"J Allergy Clin Immunol Pract"},{"key":"5772_CR23","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1002\/art.40168","volume":"69","author":"CA Perugino","year":"2017","unstructured":"Perugino CA, Mattoo H, Mahajan VS et al (2017) Emerging treatment models in rheumatology: IgG4-related disease: insights into human immunology and targeted therapies. Arthritis Rheumatol 69:1722\u20131732","journal-title":"Arthritis Rheumatol"},{"key":"5772_CR24","doi-asserted-by":"publisher","first-page":"e201800050","DOI":"10.26508\/lsa.201800050","volume":"1","author":"T Maehara","year":"2018","unstructured":"Maehara T, Mattoo H, Mahajan VS et al (2018) The expansion in lymphoid organs of IL-4 (+) BATF (+) T follicular helper cells is linked to IgG4 class switching in vivo. Life Sci Alliance 1:e201800050","journal-title":"Life Sci Alliance"},{"key":"5772_CR25","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1056\/NEJM199712113372403","volume":"337","author":"GK Hershey","year":"1977","unstructured":"Hershey GK, Friedrich MF, Esswein LA et al (1977) The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 337:1720\u20131725","journal-title":"N Engl J Med"},{"key":"5772_CR26","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.bbadis.2017.07.038","volume":"1864","author":"DC Trampert","year":"2018","unstructured":"Trampert DC, Hubers LM, van de Graaf SFJ et al (2018) On the role of IgG4 in inflammatory conditions: lessons for IgG4-related disease. Biochim Biophys Acta Mol Basis Dis 1864:1401\u20131409","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"5772_CR27","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1365-2222.1997.tb00727.x","volume":"27","author":"JC Garcia-Robaina","year":"1977","unstructured":"Garcia-Robaina JC, de la Torre-Morin F, Vazquez-Moncholi C, Fierro J et al (1977) The natural history of Apis-specific IgG and IgG4 in beekeepers. Clin Exp Allergy 27:418\u2013423","journal-title":"Clin Exp Allergy"},{"key":"5772_CR28","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.jaci.2012.08.037","volume":"131","author":"E-M Varga","year":"2013","unstructured":"Varga E-M, Kausar F, Aberer W et al (2013) Tolerant beekeepers display venom-specific functional IgG4 antibodies in the absence of specific IgE. J Allergy Clin Immunol 131:1419\u20131421","journal-title":"J Allergy Clin Immunol"},{"key":"5772_CR29","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1038\/jcbfm.2013.160","volume":"33","author":"I St-Amour","year":"2013","unstructured":"St-Amour I, Par\u00e9 I, Alata W, Coulombe K, Ringuette-Goulet C, Drouin-Ouellet J et al (2013) Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood-brain barrier. J Cereb Blood Flow Metab 33:1983\u20131992","journal-title":"J Cereb Blood Flow Metab"},{"key":"5772_CR30","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1111\/1756-185X.13693","volume":"22","author":"A Erden","year":"2019","unstructured":"Erden A, Bolek EC, Yardimci KG et al (2019) Do ANCA-associated vasculitides and IgG4-related disease really overlap or not? Int J Rheum Dis 22:1926\u20131932","journal-title":"Int J Rheum Dis"},{"key":"5772_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40266-018-0534-6","volume":"35","author":"M Akiyama","year":"2018","unstructured":"Akiyama M, Takeuchi T (2018) IgG4-related disease: beyond glucocorticoids. Drugs Aging 35:275\u2013287","journal-title":"Drugs Aging"},{"key":"5772_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10067-005-0118-9","volume":"26","author":"CP Mavragani","year":"2007","unstructured":"Mavragani CP, Voulgarelis M (2007) Retroperitoneal fibrosis and c-ANCA positivity. Clin Rheumatol 26:115\u2013116","journal-title":"Clin Rheumatol"},{"key":"5772_CR33","first-page":"779","volume":"23","author":"O Kaipiainen-Sepp\u00e4nen","year":"1996","unstructured":"Kaipiainen-Sepp\u00e4nen O, Jantunen E, Kuusisto J et al (1996) Retroperitoneal fibrosis with antineutrophil cytoplasmic antibodies. J Rheumatol 23:779\u2013781","journal-title":"J Rheumatol"},{"key":"5772_CR34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.5414\/CNP70251","volume":"70","author":"P Mart\u00ednez-Odriozola","year":"2008","unstructured":"Mart\u00ednez-Odriozola P, Guti\u00e9rrez-Mac\u00edas A, Moina Eguren I et al (2008) Association of idiopathic retroperitoneal fibrosis, rapidly progressive glomerulonephritis and antiproteinase 3 antineutrophil cytoplasmic antibodies (anti PR3-ANCA). Clin Nephrol 70:251\u2013254","journal-title":"Clin Nephrol"},{"key":"5772_CR35","unstructured":"Health Promotion Administration, Ministry of Health & Welfare, Taiwan, 2019.\u00a0https:\/\/www.hpa.gov.tw\/Pages\/Detail.aspx?nodeid=1718&pid=9913. Accessed\u00a08 May 2019"},{"key":"5772_CR36","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3109\/s10165-011-0520-x","volume":"22","author":"M Yamamoto","year":"2012","unstructured":"Yamamoto M, Takahashi H, Tabeya T et al (2012) Risk of malignancies in IgG4-related disease. Mod Rheumatol 22:414\u2013418","journal-title":"Mod Rheumatol"},{"key":"5772_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2169\/internalmedicine.53.1342","volume":"53","author":"K Hirano","year":"2014","unstructured":"Hirano K, Tada M, Sasahira N et al (2014) Incidence of malignancies in patients with IgG4-related disease. Intern Med 53:171\u2013176","journal-title":"Intern Med"},{"key":"5772_CR38","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3899\/jrheum.150436","volume":"42","author":"J Asano","year":"2015","unstructured":"Asano J, Watanabe T, Oguchi T et al (2015) Association between Immunoglobulin G4-related disease and malignancy within 12 years after diagnosis: an analysis after longterm followup. J Rheumatol 42:2135\u20132142","journal-title":"J Rheumatol"},{"key":"5772_CR39","doi-asserted-by":"publisher","first-page":"803876","DOI":"10.1155\/2014\/803876","volume":"2014","author":"H Kenichi","year":"2014","unstructured":"Kenichi H, Nakanuma Y (2014) Cholangiocarcinoma with respect to IgG4 reaction. Int J Hepatol 2014:803876. https:\/\/doi.org\/10.1155\/2014\/803876","journal-title":"Int J Hepatol"},{"key":"5772_CR40","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.1038\/s41598-020-61585-z","volume":"10","author":"H Tang","year":"2020","unstructured":"Tang H, Yang H, Zhang P et al (2020) Malignancy and IgG4-related disease: the incidence, related factors and prognosis from a prospective cohort study in China. Sci Rep 10:4910. https:\/\/doi.org\/10.1038\/s41598-020-61585-z","journal-title":"Sci Rep"},{"key":"5772_CR41","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jaci.2016.07.007","volume":"138","author":"RM Maizels","year":"2016","unstructured":"Maizels RM, McSorley HJ (2016) Regulation of the host immune system by helminth parasites. J Allergy Clin Immunol 138:666\u2013675. https:\/\/doi.org\/10.1016\/j.jaci.2016.07.007","journal-title":"J Allergy Clin Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05772-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05772-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05772-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T16:19:35Z","timestamp":1641313175000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05772-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,29]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["5772"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05772-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,29]]},"assertion":[{"value":"3 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}